Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cimicifuga Racemosa for vascular effects in postmenopausal women
NCT03786809Completed
- Sponsor
- Universidade Federal de Minas Gerais
- Start
- Jun 2016
- Primary completion
- Apr 2019
- Modality
- Botanical Extract, Dietary Supplement
- Countries
- 1
01
Overview
Randomised, double-blind trial in menopause comparing Cimicifuga Racemosa Arm with Placebo Arm (2 arms). Primary endpoint: Flow-Mediated Dilatation of brachial artery at 28 days. Started Jun 2016; status: completed.
02
Drugs
cimicifuga racemosa
03
Conditions
menopause
Beyond the preview
Go deeper on NCT03786809.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03786809.